CAD 0.02
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.00 CAD | 14.29% |
2022 | -0.00 CAD | 17.65% |
2021 | -0.00 CAD | 59.04% |
2020 | -0.01 CAD | 7.78% |
2019 | -0.01 CAD | 75.87% |
2018 | -0.04 CAD | -15.48% |
2017 | -0.03 CAD | -96.95% |
2016 | -0.02 CAD | -281.4% |
2015 | -0.00 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.00 CAD | 50.0% |
2024 Q2 | -0.00 CAD | -75.0% |
2023 Q4 | -0.00 CAD | -100.0% |
2023 Q3 | -0.00 CAD | 0.0% |
2023 Q1 | -0.00 CAD | -216.67% |
2023 FY | - CAD | 14.29% |
2023 Q2 | -0.00 CAD | 42.86% |
2022 Q1 | -0.00 CAD | -100.0% |
2022 Q3 | -0.00 CAD | -36.36% |
2022 Q4 | 0.00 CAD | 140.0% |
2022 Q2 | -0.00 CAD | 38.89% |
2022 FY | - CAD | 17.65% |
2021 FY | - CAD | 59.04% |
2021 Q1 | -0.00 CAD | 69.7% |
2021 Q4 | -0.00 CAD | 0.0% |
2021 Q3 | - CAD | 100.0% |
2021 Q2 | -0.00 CAD | -50.0% |
2020 Q3 | 0.00 CAD | 121.28% |
2020 FY | - CAD | 7.78% |
2020 Q1 | -0.00 CAD | -550.0% |
2020 Q2 | -0.00 CAD | -261.54% |
2020 Q4 | -0.00 CAD | -430.0% |
2019 Q3 | -0.00 CAD | 65.12% |
2019 Q2 | -0.00 CAD | -43.33% |
2019 Q4 | -0.00 CAD | 86.67% |
2019 Q1 | -0.00 CAD | 79.73% |
2019 FY | - CAD | 75.87% |
2018 Q1 | -0.01 CAD | 47.75% |
2018 FY | - CAD | -15.48% |
2018 Q4 | -0.01 CAD | -120.9% |
2018 Q3 | -0.01 CAD | 22.09% |
2018 Q2 | -0.01 CAD | -48.28% |
2017 Q1 | -0.00 CAD | 22.95% |
2017 Q2 | -0.01 CAD | -53.19% |
2017 Q3 | -0.00 CAD | 38.89% |
2017 FY | - CAD | -96.95% |
2017 Q4 | -0.01 CAD | -152.27% |
2016 Q3 | -0.01 CAD | -305.56% |
2016 Q1 | -0.00 CAD | -105.26% |
2016 Q2 | -0.00 CAD | 53.85% |
2016 FY | - CAD | -281.4% |
2016 Q4 | -0.01 CAD | 16.44% |
2015 Q4 | -0.00 CAD | -375.0% |
2015 FY | - CAD | 0.0% |
2015 Q3 | -0.00 CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -0.45 CAD | 99.467% |
Asep Medical Holdings Inc | -0.13 CAD | 98.154% |
BetterLife Pharma Inc. | -0.03 CAD | 90.909% |
BioVaxys Technology Corp. | -0.06 CAD | 95.812% |
ChitogenX Inc. | -0.02 CAD | 88.732% |
Rapid Dose Therapeutics Corp. | -0.04 CAD | 94.146% |
Defence Therapeutics Inc. | -0.30 CAD | 99.2% |
Entheon Biomedical Corp. | -0.05 CAD | 95.276% |
Gemina Laboratories Ltd. | -0.07 CAD | 96.667% |
Glow Lifetech Corp. | -0.03 CAD | 91.667% |
Lexston Life Sciences Corp. | -0.02 CAD | 89.565% |
Pharmala Biotech Holdings Inc. | -0.01 CAD | 73.913% |
Doseology Sciences Inc. | -0.08 CAD | 96.989% |
MYND Life Sciences Inc. | -0.03 CAD | 92.523% |
Nova Mentis Life Science Corp. | -0.01 CAD | 71.084% |
PharmaTher Holdings Ltd. | -0.04 CAD | 93.201% |
Telescope Innovations Corp. | -0.12 CAD | 98.0% |